Join Graeme Smith our CSO and Helen Robinson, VP of Biology during the聽聽from January 25-27. The summit will highlight the new and novel next-generation DDR therapeutics, biomarker understanding and optimal treatment combinations for an array of cancer indications. Join us to learn more!
Graeme Smith, CSO and Helen Robinson, VP Biology attending the 5th Digital DDR, ATR, & PARP Summit 鈥� 25/26 January 2022
| Conferences